Answers are grounded in this paper and cite their sources.
Controversy continues to roil around the role of PSA screening in prostate cancer. The authors review the available data and its quality and conclude that the evidence does not indicate that the benefits outweigh the harms.
No takes yet. Share an insight, caveat, or question.
Pinsky et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: